CDKN2A and mesothelioma: We previously reported that Ad-delE1B increased p53 levels and induced apoptosis in wild-type p53 mesothelioma with CDKN2A deletion, and suggested a role of p53 in Ad-delE1B-induced cytotoxicity [11].